focus -WSS

focus

author：entertainment 2025-10-01 05:39:26 - browse：182

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： CDC advisory group OKs chikungunya vaccine

knowledge

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Medicare Advantage isn’t working — for anyone

Be careful with at

Health AI: on the border between health care and tech

Cholera vaccine supplies dangerously low, outbreaks surging

Change Healthcare cyberattack shows risk of industry consolidation

focus

focus

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Surge in Apellis stock fueled by confidence in safety of its eye drug

Psychedelics group wrestles with new pharma identity

Are embryos people? Reproductive medicine's future depends on the answer

Bright Health sells Medicare Advantage business to Molina

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Apple is now the first public company to be valued at $3 trillion

'Vaccine

After affirmative action ruling, medical educators look to 'holistic review'

Mark Cuban is blaming the wrong people for high drug costs

knowledge

Medicare Advantage isn’t working — for anyone

Neuroscience renaissance leads to new crop of psychiatric drugs

Biogen’s boardroom scandal saddles CEO with first crisis

Using force crossed my mind when examining a defiant young patient

Pfizer is about to make a big push in cancer. Will investors listen?

Elisabeth Bik tackles the widespread issue of research misconduct

hotspot

knowledge

Wikipedia

hotspot